The expression of miR-155 has been implicated in lymphoid malignancies and is mediated by several oncogenic herpes viruses[21–23] to viral tumourigenesis, while the activation of TLR3 is involved in tumour suppression[5, 38, 39] via the recruiting of an anti-tumoural immune response. Here, TLR3 is linked to neoplasm.